114 related articles for article (PubMed ID: 38926073)
1. Corrigendum to "Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine" [Int. Immunopharmacol. 131 (2024) 111817].
Yu X; Min H; Yao S; Yao G; Zhang D; Zhang B; Chen M; Liu F; Cui L; Zheng L; Cao Y
Int Immunopharmacol; 2024 Jun; ():112260. PubMed ID: 38926073
[No Abstract] [Full Text] [Related]
2. Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine.
Yu X; Min H; Yao S; Yao G; Zhang D; Zhang B; Chen M; Liu F; Cui L; Zheng L; Cao Y
Int Immunopharmacol; 2024 Apr; 131():111817. PubMed ID: 38460299
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants" [Int. Immunopharmacol. 101(Part B) (2021) 108216].
He L; Sun B; Guo Y; Yan K; Liu D; Zang Y; Jiang C; Zhang Y; Kong W
Int Immunopharmacol; 2023 Jun; 119():110260. PubMed ID: 37150708
[No Abstract] [Full Text] [Related]
4. Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with various adjuvants, as a transmission blocking vaccine.
Pourhashem Z; Nourani L; Sani JJ; Yousefi H; Pirahmadi S; Sabouri M; Raz A; Djadid ND; Zakeri S; Mehrizi AA
Malar J; 2023 Dec; 22(1):374. PubMed ID: 38071314
[TBL] [Abstract][Full Text] [Related]
5. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
Zhang Y; Ji T; Ma S; Wu W
Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Baicalin suppresses IL-1β-induced expression of inflammatory cytokines via blocking NF-κB in human osteoarthritis chondrocytes and shows protective effect in mice osteoarthritis models" [Int. Immunopharmacol. 52 (2017) 218-226].
Chen C; Zhang C; Cai L; Xie H; Hu W; Wang T; Lu D; Chen H
Int Immunopharmacol; 2021 Jun; 95():107546. PubMed ID: 33735716
[No Abstract] [Full Text] [Related]
7. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.
Chowdhury DR; Angov E; Kariuki T; Kumar N
PLoS One; 2009 Jul; 4(7):e6352. PubMed ID: 19623257
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "Evaluation of the immunomodulatory and anti-inflammatory activity of Bakuchiol using RAW 264.7 macrophage cell lines and in animal models stimulated by lipopolysaccharide (LPS)" [Int. Immunopharmacol. 91 (2021) 107264].
Kumar A; Sawhney G; Kumar Nagar R; Chauhan N; Gupta N; Kaul A; Ahmed Z; Sangwan PL; Satheesh Kumar P; Yadav G
Int Immunopharmacol; 2022 Oct; 111():109003. PubMed ID: 35778365
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Different roles of bortezomib and ONX 0914 in acute kidney injury" [Int. Immunopharmacol. 82 (2020) 106259].
Zhang XZ; Han F; Ding CG; Dou M; Wang YX; Xue WJ; Ding XM; Zheng J; Xu CX; Tian PX
Int Immunopharmacol; 2024 Jan; 126():111189. PubMed ID: 38012900
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Leukotriene D4 induces cellular senescence in osteoblasts" [Int. Immunopharmacol. 58 (2018)154-159].
Wei J; Chen S; Guo W; Feng B; Yang S; Huang C; Chu J
Int Immunopharmacol; 2024 Mar; 129():111673. PubMed ID: 38365537
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice" [Int. Immunopharmacol. 102 (2022) 108411].
Hao J; Sun W; Xu H
Int Immunopharmacol; 2022 Mar; 104():108550. PubMed ID: 35067473
[No Abstract] [Full Text] [Related]
12. Corrigendum to "IDO1: An important immunotherapy target in cancer treatment" [Int. Immunopharmacol. 47 (2017) 70-77].
Li F; Zhang R; Li S; Liu J
Int Immunopharmacol; 2017 Aug; 49():231. PubMed ID: 28457914
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Modulating endoplasmic reticulum stress attenuates mast cell degranulation" [Int. Immunopharmacol. 126 (2024) 111336].
Fan J; Ma L; Xie B; Qiu S; Song S; Tang Z; Wu Y; Huangfu H; Feng Y; Luo X; Yang P
Int Immunopharmacol; 2024 Jun; ():112497. PubMed ID: 38902129
[No Abstract] [Full Text] [Related]
14. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Neuroprotective effect of Vesatolimod in an experimental autoimmune encephalomyelitis mice model" [Int. Immunopharmacol. 116 (2023) 109717].
Jiang X; Song Y; Fang J; Yang X; Mu S; Zhang J
Int Immunopharmacol; 2024 Feb; 128():111448. PubMed ID: 38191277
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generation" [Int. Immunopharmacol. 111 (2022) 108855].
Jiang H; Niu C; Guo Y; Liu Z; Jiang Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111146. PubMed ID: 37926666
[No Abstract] [Full Text] [Related]
17. Corrigendum to "The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics" [Int. Immunopharmacol. 118 (2023) 110081].
Ghosh M; Rana S
Int Immunopharmacol; 2023 Dec; 125(Pt A):111089. PubMed ID: 37872057
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation" [Int. Immunopharmacol. 73 (2019) 304-311].
Zheng Y; Zhu G; He J; Wang G; Li D; Zhang F
Int Immunopharmacol; 2020 Nov; 88():107004. PubMed ID: 32950402
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Effect of chlorogenic acid on mast cell-dependent anaphylactic reaction" [Int. Immunopharmacol. 10 (2010) 1135-1141].
Qin HD; Shi YQ; Liu ZH; Li ZG; Wang HS; Wang H; Liu ZP
Int Immunopharmacol; 2019 Nov; 76():105863. PubMed ID: 31473097
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Immune-enhancing effects of polysaccharides extracted from Lilium lancifolium Thunb" [Int. Immunopharmacol. 52 (2017) 119-126].
Pan G; Xie Z; Huang S; Tai Y; Cai Q; Jiang W; Sun J; Yuan Y
Int Immunopharmacol; 2018 May; 58():186. PubMed ID: 29599101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
